www.lesswrong.com/posts/bMxhrrkJdEormCcLt/brute-force-manufactured-consensus-is-...

The quoted characterization overstates what the Lancet letter actually said.

In the letter itself, the authors wrote: "We stand together to strongly condemn conspiracy theories suggesting that COVID-19 does not have a natural origin." That is not the same as condemning any discussion of a possible lab leak. The article's wording turns a specific statement about "conspiracy theories" into a blanket claim about all discussion of the hypothesis.

This distinction matters because readers can verify the letter's text directly in PubMed Central. Whatever one thinks about the letter's effect on public debate, its published wording does not match the article's paraphrase here.

This claim confuses the start of a public controversy with the start of the research itself.

A 2015 National Academies workshop summary states that information from gain-of-function studies had been used "perhaps even as far back as the 1970s." Likewise, a 2015 Nature Reviews Microbiology article explains that the debate intensified because of recent influenza studies, but also says that "Virology is founded on adaptation approaches" and warns against equating gain-of-function work only with the 2011 influenza-transmission experiments.

There are also concrete pre-2011 examples. In 2001, Nature Biotechnology reported that Australian researchers had accidentally engineered a much more virulent mousepox virus after inserting an IL-4 gene.

So 2011 was an important date in the policy debate over certain high-risk experiments, but it was not when gain-of-function research "really started."

This wording is too broad.

In October 2014, NIH announced a "funding pause on certain gain-of-function research projects". The notice says the pause applied to projects involving influenza, MERS, or SARS viruses that were reasonably anticipated to enhance pathogenicity and/or transmissibility in mammals via the respiratory route. It also explicitly says the pause did not apply to characterization or testing of naturally occurring viruses unless those tests were expected to increase transmissibility or pathogenicity, and that exceptions could be granted when urgently necessary.

The same notice also says NIH would continue to accept new applications involving gain-of-function studies; the issue was whether funding would be released for projects falling within the pause criteria. In December 2017, NIH announced the removal of that pause after adoption of the HHS P3CO framework.

So describing 2014 simply as "funding was banned" is inaccurate. The policy was a targeted funding pause, not a blanket ban on all gain-of-function funding.